Sungwon Yoo

Accomplished Clinical Research Coordinator and ICU Nurse with a proven track record at Korea Guro Hospital and Hallym University Sacred Heart Hospital. Expert in Clinical Research Ethics and adept at fostering teamwork. Enhanced patient care and research protocol adherence, training team members, and improving communication processes.

• EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2-Early Breast Cancer with an Increased Risk of Recurrence (Jan. 2024-Oct.2024)
• Korean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) II (Jan. 2024-Oct.2024)
• Single-POrt Robot-assisted thoracic surgery versus single port video-assisted Thoracic Surgery major pulmonary resection for patients with non-small cell lung cancer (SPORTS trial): a single-center,single blinded, randomized controlled trial (Jan.2024-Oct.2024)
• A 6-month multicenter, randomized, double-blind, placebo controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to
• A Prospective study for cancer diagnosis and prognosis through analysis exosomes in patients received thoracic cancer surgery (Jan. 2024-Oct.2024)
• A Multicenter, Randomized, Double-blind, Restasis® Controlled Non-inferiority, Moisview® Eye Drops Controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome (Jan.2023-Jun.2024)
• A Multicenter, Active control, Parallel group, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients with Dry Eye Disease (Jan.2023-Jun.2024)
• A randomized multicenter noninferiority trial comparing chemoradiotherapy versus esophagectomy after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma (ASSURE) (Dec.2022-Sep.2024)
• Detection of circulating tumor cells in blood from peripheral blood and pulmonary blood in lung cancer patients (Dec.2022-Sep.2024)
• A Double-blind, Randomized, Multi-Center, Active Controlled Phase 2 Clinical Trial to Evaluate the Safety and Immunogenicity after MG1111(BARICELA inj.) as 2nd vaccination in 4 ~ 6 year old healthy children with a history of 1st Varicella vaccination (Dec.2022-Sep.2024)
• An investigator-initiated open-label pilot study to evaluate of cellular and humoral immunity of the current varicella vaccines in Korean healthy children (Dec.2022-Aug.2024)